# Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period

> **NCT00614536** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 1142 (actual)

## Conditions studied

- Gastroesophageal Reflux
- Pharyngeal Diseases

## Interventions

- **DRUG:** Rabeprazole Sodium

## Key facts

- **NCT ID:** NCT00614536
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 1142 (ACTUAL)
- **Last updated:** 2014-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614536, "Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00614536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*